See What HealthDay Can Do For You
Contact Us

Continuous Oral Contraceptives Better After Endometriosis Sx

Review shows reduced recurrence rates for dysmenorrhea with continuous versus cyclic schedule

birth control

TUESDAY, Feb. 16, 2016 (HealthDay News) -- For patients after surgery for endometriosis, a continuous oral contraceptive schedule seems better than a cyclic schedule, according to a review published in the February issue of the American Journal of Obstetrics & Gynecology.

Ludovico Muzii, M.D., from the Sapienza University of Rome, and colleagues conducted a systematic review and meta-analysis to compare a continuous versus a cyclic oral contraceptive schedule after surgical excision of ovarian endometriomas. Data were included from three randomized clinical trials and one prospective controlled study, with 557 patients with endometriosis, of whom 343 had ovarian endometriomas and completed the assigned treatment and follow-up.

The researchers found that a continuous schedule correlated with lower recurrence rates for dysmenorrhea (risk ratio, 0.24; 95 percent confidence interval, 0.06 to 0.91; P = 0.04). There were nonsignificant between-group differences for chronic pelvic pain and dyspareunia. Compared with a cyclic schedule, a continuous oral contraceptive schedule correlated with a nonsignificant reduction of cyst recurrence rates (risk ratio, 0.54; 95 percent confidence interval, 0.28 to 1.05; P = 0.07).

"Due to the small number and small sample sizes of the included studies, further randomized clinical trials are needed to confirm the findings of the present systematic review," the authors write. "Also, outcomes related to patient satisfaction and quality of life should be addressed."

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.